Journal of Lipid Research
Volume 49, Issue 2, February 2008, Pages 308-323
Journal home page for Journal of Lipid Research

Research Article
Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissues⃞

https://doi.org/10.1194/jlr.M700199-JLR200Get rights and content
Under a Creative Commons license
open access

Obesity and insulin resistance are independent risk factors for metabolic syndrome, diabetes, and cardiovascular disease. Adipose tissue samples from nonobese (NO), insulin-sensitive obese (ISO), and insulin-resistant obese (IRO) subjects from subcutaneous (SC) and omental (OM) adipose tissue (n = 28) were analyzed by microarray and confirmed by real-time PCR. Insulin signaling gene expression changes were greater in OM than in SC tissue and were related to insulin resistance rather than to obesity; few genes correlated with body mass index. Insulin receptor and insulin receptor substrate 1 (IRS-1) increased in the IRO versus pooled insulin-sensitive (NO+ISO) subjects. In glucose transport, PI3Kα and PDK2 decreased in IRO subjects, whereas PI3Kγ, Akt2, GLUT4, and GLUT1 increased. IRS-1 regulators Jnk and IKK increased in IRO (P < 0.01 and P < 0.001 respectively). In protein synthesis, most genes examined were downregulated in IRO subjects, including mTor, Rheb, and 4EBP and eIF members (all P < 0.05). In proliferation, SHC, SOS, and Raf1 (P < 0.05) were increased, whereas Ras and MEK1/2 kinase 1 (P < 0.05) were decreased, in IRO subjects. Finally, in differentiation, PPARγ, CEBPα, and CEBPβ decreased, whereas PPARδ, CEBPγ, and CEBPϵ increased, in IRO subjects (P < 0.05). Together, microarray and real-time PCR data demonstrate that insulin resistance rather than obesity is associated with altered gene expression of insulin signaling genes, especially in OM adipose tissue.

differentiation
glucose
proliferation
protein synthesis
insulin-sensitive obese
insulin-resistant obese

Cited by (0)

Published, JLR Papers in Press, November 6, 2007.

    Abbreviations

    BMI

    body mass index

    cRNA

    complimentary RNA

    FDR

    false discovery rate

    HOMA-IR

    homeostasis model assessment insulin resistance

    InsR

    insulin receptor

    IRO

    insulin-resistant obese

    IRS-1

    insulin receptor substrate 1

    ISO

    insulin-sensitive obese

    NIDDM

    non-insulin-dependent diabetes mellitus

    NO

    nonobese

    OM

    omental

    SAM

    Significant Analysis of Microarrays

    SC

    subcutaneous

s⃞

The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of two tables.